Articles

Virtual Reality (VR) technology enables a new form of exposure therapy through the creation of a so-called virtual world, known as “in-virtuo” exposure.

Treatment-resistant depression (TRD) represents a significant clinical challenge, affecting approximately 30% of individuals with major depressive disorder (MDD) who fail to respond to at least two adequate antidepressant trials.

This article examines the limitations of current treatments for anxiety disorders and surveys promising new pharmacological approaches such as novel GABAergic agents, psychedelics, and neuropeptide modulators.

This article reviews the shift towards more personalised care by integrating biological and clinical profiles to guide mechanism-based, targeted interventions across psychiatric conditions.

This article discusses potential next steps for enhancing clinical trial outcomes in neurodegenerative diseases, with the ultimate goal of improving patient care

This article discusses the major developments that have taken place in the PD genetics field, and provides an understanding of why and how genetics is increasingly being integrated into day-to-day clinical and research practice.